Valereum PLC - Market Update
RNS Number : 6883D
Valereum PLC
21 October 2022

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR")


Logo Description automatically generated

21 October 2022

Valereum Plc

("Valereum" or the "Company")


Market Update


Further to the Company announcement on 17th October 2022 regarding the proposed completion of the acquisition of the Gibraltar Stock Exchange ("GSX), Valereum confirms that it is continuing constructive discussions with the Gibraltar Financial Services Commission ("GFSC") regarding the closing of the transaction. These discussions on the regulatory change of control of the GSX are constructive and solid progress is being made.


As stated previously, Valereum's management team is working towards completing the acquisition and will update the market when significant news arises.



The Directors of the Company accept responsibility for the contents of this announcement.




Valereum Plc

Richard Poulden, Chairman

Tel: +971 4584 6284


AQSE Corporate Adviser

First Sentinel Corporate Finance

Brian Stockbridge

Tel: +44 (0) 7876 888 011


Investor Relations

J&H Communications Limited

James Henderson

Tel: +44 (0)7774 444163


George Hudson

Tel: +44 (0)7803 603130


For more information, please visit the Company's website at

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.